Für die Filterung wurden keine Ergebnisse gefunden!
Spike (Epsilon B.1.429 Variant) Pseudotyped Lentivirus... Artikelnummer: BPS-78172-1
The Spike (Epsilon B.1.429 Variant) (SARS-CoV-2) Pseudotyped Lentiviruses were produced with SARS-CoV-2 B.1.429 Variant Spike (Genbank Accession #QHD43416.1 with B.1.429 variant mutations, see below for details) as the envelope glycoproteins instead of the commonly used VSV-G. These pseudovirions contain the firefly...
| Schlagworte: | 2, |
| Anwendung: | Viral transduction studies, Neutralizing antibody screening |
| Reaktivität: | Sars-cov-2 |
ab 998,00 €
Spike (SARS-CoV-2 B.1.617 (Delta/Kappa parental) Variant)... Artikelnummer: BPS-78204-1
The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
| Schlagworte: | 2, |
| Anwendung: | Viral transduction studies, Neutralizing antibody screening |
| Reaktivität: | Sars-cov-2 |
ab 998,00 €
Spike (SARS-CoV-2 Kappa B.1.617.1 Variant) Pseudotyped... Artikelnummer: BPS-78205-1
The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
| Schlagworte: | 2, |
| Anwendung: | Viral transduction studies, Neutralizing antibody screening |
| Reaktivität: | Sars-cov-2 |
ab 998,00 €
Spike (SARS-CoV-2 B.1.618 Variant) Pseudotyped Lentivirus... Artikelnummer: BPS-78206-1
The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
| Schlagworte: | 2, |
| Anwendung: | Viral transduction studies, Neutralizing antibody screening |
| Reaktivität: | Sars-cov-2 |
ab 998,00 €
Cas9 Lentivirus (Hygromycin Selection) Artikelnummer: BPS-78067
Cas9 Lentivirus can be used to generate Cas9 expressing cells in almost any mammalian cell line. Cells stably expressing Cas9 can then be transduced or electroporated with sgRNA targeting a gene of interest to quickly generate knock-out cell pools or cell lines. The Cas9 Lentiviruses are replication incompetent,...
| Schlagworte: | SpCas9, SpyCas9, SPy_1046, CRISPR-associated endonuclease Cas9/Csn1 |
| Anwendung: | Transient Cas9 expression, Stable Cas9 over-expressing cell line generation (hygromycin selection) |
998,00 €
COVID-19 Forschung
Spike (K417T, E484K, N501Y) (SARS-CoV-2) Pseudotyped... Artikelnummer: BPS-78143-1
The Spike (K417T, E484K, N501Y) (SARS-CoV-2) Pseudotyped Lentiviruses were produced with SARS-CoV-2 Variant Spike (Genbank Accession #QHD43416.1 with mutations K417T, E484K, and N501Y) as the envelope glycoproteins instead of the commonly used VSV-G. These pseudovirions contain the firefly luciferase gene driven by...
| Schlagworte: | 2 |
| Anwendung: | Viral transduction studies, Neutralizing antibody screening |
| Reaktivität: | Sars-cov-2 |
ab 998,00 €
COVID-19 Forschung
Spike (gamma P.1 Variant) (SARS-CoV-2) Pseudotyped... Artikelnummer: BPS-78144-1
In Brazil, a variant called P.1 was first identified in the summer of 2020. This variant has many mutations that may lead to higher transmissibility and infectivity. The Spike (P.1) (SARS-CoV-2) Pseudotyped Lentiviruses were produced with SARS-CoV-2 Variant Spike (Genbank #QHD43416.1 with P.1 mutations (L18F, T20N,...
| Schlagworte: | 2 |
| Anwendung: | Viral transduction studies, Neutralizing antibody screening |
| Reaktivität: | Sars-cov-2 |
ab 998,00 €
COVID-19 Forschung
Spike (alpha B.1.1.7 Variant) (SARS-CoV-2) Pseudotyped... Artikelnummer: BPS-78158-1
The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
| Schlagworte: | 2 |
| Anwendung: | Viral transduction studies, Neutralizing antibody screening |
| Reaktivität: | Sars-cov-2 |
ab 998,00 €
COVID-19 Forschung
Spike (gamma P.1 Variant) (SARS-CoV-2) Pseudotyped... Artikelnummer: BPS-78159-1
The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
| Schlagworte: | 2 |
| Anwendung: | Viral transduction studies, Neutralizing antibody screening |
| Reaktivität: | Sars-cov-2 |
ab 998,00 €
COVID-19 Forschung
Spike (beta B.1.351 Variant) (SARS-CoV-2) Pseudotyped... Artikelnummer: BPS-78160-1
The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
| Schlagworte: | 2 |
| Anwendung: | Viral transduction studies, Neutralizing antibody screening |
| Reaktivität: | Sars-cov-2 |
ab 998,00 €
NF-kappaB eGFP Reporter Lentivirus Artikelnummer: BPS-79926
The NF-kappaB eGFP Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. The particles contain an enhanced GFP gene driven by the NF-kappaB response element located...
| Schlagworte: | RELA, NFKB3, Transcription factor p65, Nuclear factor NF-kappa-B p65 subunit, Nuclear factor of kappa light polypeptide... |
| Anwendung: | NFkB signaling pathway activator/inhibitor screening, NFkB eGFP reporter stable cell line generation |
| Reaktivität: | Human |
998,00 €
Negative Control eGFP Reporter Lentivirus Artikelnummer: BPS-79927
The Negative Control eGFP Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. The particles contain an enhanced Green Fluorescent Protein (eGFP) gene under the...
| Schlagworte: | GFP, Green fluorescent protein |
| Anwendung: | EGFP reporter activity background determination, Establishing lentivirus reporter system specificity |
| Reaktivität: | Mammalian |
998,00 €